Ex vivo culture of human prostate tissue and drug development (Q38113460)

29 August 2017

title

Ex vivo culture of human prostate tissue and drug development (English)

1 reference

29 August 2017

Margaret M Centenera

0 references

Lisa M Butler

0 references

Karen E Knudsen

0 references

Ganesh V Raj

1 reference

29 August 2017

Wayne D Tilley

series ordinal

1 reference

29 August 2017

language of work or name

English

0 references

publication date

11 June 2013

1 reference

29 August 2017

published in

Nature Reviews Urology

1 reference

29 August 2017

1 reference

29 August 2017

1 reference

29 August 2017

page(s)

483-487

1 reference

Why is cancer drug discovery so difficult?

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

STUDIES ON PROSTATIC CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Abiraterone and increased survival in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Increased survival with enzalutamide in prostate cancer after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

The Valley of Death in anticancer drug development: a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Tumor microenvironment complexity: emerging roles in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Breaking through a roadblock in prostate cancer research: an update on human model systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Human prostate cancer heterotransplants: a review on this experimental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Three-dimensional cell culture: the missing link in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Organ culture of benign, aging, and hyperplastic human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

The Effect of Testosterone on the Human Prostate in Organ Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Culturing precision-cut human prostate slices as an in vitro model of prostate pathobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Human prostate epithelium lacks Wee1A-mediated DNA damage-induced checkpoint enforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Dual roles of PARP-1 promote cancer growth and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Bcl-2 modulation to activate apoptosis in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Measurement of androgen sensitivity in the human prostate in in vitro three-dimensional histoculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

DNA damage recognition via activated ATM and p53 pathway in nonproliferating human prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Biomarker-driven early clinical trials in oncology: a paradigm shift in drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

AACR-FDA-NCI Cancer Biomarkers Collaborative consensus report: advancing the use of biomarkers in cancer drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Estradiol causes the rapid accumulation of cAMP in human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

New sensitive discovery histoculture model for growth-inhibition studies in prostate cancer and BPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Comparison of androgen-independent growth and androgen-dependent growth in BPH and cancer tissue from the same radical prostatectomies in sponge-gel matrix histoculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Morphological Responses of Prostatic Carcinoma to Testosterone in Organ Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Morphological changes of benign prostatic hyperplasia in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue in organ cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Establishment of an organotypic in vitro culture system and its relevance to the characterization of human prostate epithelial cancer cells and their stromal interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Adenoviral Gene Expression and Replication in Human Tumor Explant Models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Culture of cells as a monolayer derived from the epithelium of the human prostate: a new cell growth technique

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Organ culture studies of human prostatic adenocarcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2013.126

Studies on carcinogenesis of human prostate. II. Long-term explant culture of normal prostate and benign prostatic hyperplasia: light microscopy

31 March 2020

1 reference

12 December 2020

Hormone regulation of human prostate in organ culture

1 reference

12 December 2020

In vitro maintenance of human hyperplastic prostate tissue

1 reference

12 December 2020

Studies on human hyperplastic prostates maintained in organ culture

1 reference

12 December 2020

Characteristics of nonmalignant and malignant human prostate in organ culture

1 reference

12 December 2020

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2013.126

1 reference

Dimensions Publication ID

29 August 2017

1038613607

0 references

1 reference